Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wass

Showing results (61-70 of 249) with videos related to

Pageof 25
Sort By:
British Medical Journal (Clinical Research Ed.)|September 6, 1986
Late diagnosis of pituitary and parapituitary lesions causing visual failureK P Moore, J A Wass, G M Besser
Clinical Endocrinology|September 1, 1993
The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fastingA M Cotterill, J M Holly, J A Wass
Acta Endocrinologica. Supplementum|January 1, 1978
Acromegaly--results of long term treatment with bromocriptineG M Besser, J A Wass, M O Thorner
Lancet (London, England)|May 22, 1976
Letter: Digital vasospasm with bromocriptineJ A Wass, M O Thorner, G M Besser
Infection and Immunity|January 1, 1996
Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrierN V Prasadarao, C A Wass, K S Kim
Clinical Endocrinology|February 13, 2001
Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndromeM Elsheikh, B Casadei, G S Conway, et al.
Regulatory Peptides|September 1, 1984
Bombesin-like immunoreactivity in human gastrointestinal tractJ Price, E Penman, J A Wass, et al.
Clinical Endocrinology|February 1, 1986
Depot-bromocriptine treatment for prolactinomas and acromegalyA Grossman, R Ross, J A Wass, et al.
British Medical Journal|January 18, 1975
Renal excretion of fluoride in renal failure and after renal transplantationV Parsons, A A Choudhury, J A Wass, et al.
Clinical Endocrinology|September 1, 1999
A comparison of lanreotide and octreotide LAR for treatment of acromegalyH E Turner, A Vadivale, J Keenan, et al.
Pageof 25

Showing results (61-70 of 249) with videos related to

Sort By:
Pageof 25
British Medical Journal (Clinical Research Ed.)|September 6, 1986
Late diagnosis of pituitary and parapituitary lesions causing visual failureK P Moore, J A Wass, G M Besser
Clinical Endocrinology|September 1, 1993
The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fastingA M Cotterill, J M Holly, J A Wass
Acta Endocrinologica. Supplementum|January 1, 1978
Acromegaly--results of long term treatment with bromocriptineG M Besser, J A Wass, M O Thorner
Lancet (London, England)|May 22, 1976
Letter: Digital vasospasm with bromocriptineJ A Wass, M O Thorner, G M Besser
Infection and Immunity|January 1, 1996
Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrierN V Prasadarao, C A Wass, K S Kim
Clinical Endocrinology|February 13, 2001
Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndromeM Elsheikh, B Casadei, G S Conway, et al.
Regulatory Peptides|September 1, 1984
Bombesin-like immunoreactivity in human gastrointestinal tractJ Price, E Penman, J A Wass, et al.
Clinical Endocrinology|February 1, 1986
Depot-bromocriptine treatment for prolactinomas and acromegalyA Grossman, R Ross, J A Wass, et al.
British Medical Journal|January 18, 1975
Renal excretion of fluoride in renal failure and after renal transplantationV Parsons, A A Choudhury, J A Wass, et al.
Clinical Endocrinology|September 1, 1999
A comparison of lanreotide and octreotide LAR for treatment of acromegalyH E Turner, A Vadivale, J Keenan, et al.
Pageof 25